Clinical Trial Update: Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating bone marrow autologous mesenchymal stem cells for lumbar degenerative disc disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• MSV – Bone marrow autologous mesenchymal stem cells (Bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Degenerative Disc Disease | Phase 1, Phase 2 | Status: WITHDRAWN